FDA Adverse Event Other Summary report: N

EVOLIS MICROPLATE SYSTEM

MDR report key: 3313764 · Received August 20, 2013

Report

Report Number
3022521-2013-00002
Event Type
Other
Date Received
August 20, 2013
Date of Event
July 24, 2013
Report Date
August 19, 2013
Manufacturer
BIO-RAD LABORATORIES, INC.
Product Code
LOL
PMA / PMN Number
K092353
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

ON (B)(6) 2013, A CUSTOMER CALLED BIO-RAD LABORATORIES TECHNICAL SUPPORT DEPARTMENT TO REPORT THAT WHEN REPORTING RESULTS FROM AN (B)(6) TESTING RUN, THEY MADE A TRANSCRIPTION ERROR. THIS TRANSCRIPTION ERROR RESULTED IN THE CUSTOMER INCORRECTLY REPORTING A PT AS (B)(6) WHEN THE SAMPLE WAS ACTUALLY INITIALLY (B)(6) ON THE (B)(6). THE CUSTOMER REPORTED THAT THE (B)(6) TESTING RUN INVOLVED IN THE ISSUE INCLUDED A NUMBER OF SAMPLES, THREE OF WHICH WERE BEING TESTED IN DUPLICATE FOLLOWING INITIALLY (B)(6) RESULTS. THE SAMPLE INVOLVED IN THE TRANSCRIPTION ERROR WAS A NEW PT SAMPLE THAT WAS COINCIDENTALLY RUN DIRECTLY ADJACENT TO THE THREE PREVIOUSLY INITIALLY (B)(6) SAMPLES. WHEN REVIEWING THE ASSAY RESULTS REPORT, THE TECHNICIAN ACCIDENTALLY ASSOCIATED THE NEW PT SAMPLE IDENTITY WITH OTHER NON-REACTIVE PT SAMPLES THAT WERE LOCATED ON THE SAME RESULTS REPORT. SAMPLES IMMEDIATELY BELOW THE NEW INITIALLY (B)(6) PT SAMPLE WERE NON-REACTIVE. THE CUSTOMER REPORTED THAT THE ASSAY RUN WAS VALID AND THE INSTRUMENT WAS PERFORMING ACCURATELY. THE PT SAMPLE INVOLVED IN THE TRANSCRIPTION ERROR WAS INITIALLY TESTED ON (B)(6) 2013. THE TRANSCRIPTION ERROR WAS DISCOVERED BY THE CUSTOMER WHEN THE PT WAS TESTED AGAIN SIX MONTHS LATER ON (B)(6) 2013 AND A REPEATEDLY (B)(6) RESULT WAS OBTAINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
403380 EVOLIS MICROPLATE SYSTEM 4PS SYSTEM LOL BIO-RAD LABORATORIES, INC. EVOLIS

Patients

Seq Age Sex Outcome Treatment
1